1 (877) DEVANA-2 info@devanasolutions.com
Select Page

IFS

(CHAPEL HILL, NC) – October 18, 2018.   Devana Solutions, LLC (“Devana”) is pleased to join in supporting Javara’s goal of creating a more relevant clinical trial experience for value-oriented healthcare systems and their patients.   With Javara running Devana’s performance data transparency software platform, enhanced predictive clinical research delivery models become a reality, allowing for improved access to cutting edge therapies and better outcomes within patient–centered care across academic medical centers and healthcare systems.

Javara’s unqiue model and strategy to integrate clinical research within the care continuum, aligning with population health strategies of academic medical centers and healthcare systems, stands to revolutionize the way in which clinical trials are conducted.  Javara’s CEO and Board Chair, Jennifer Byrne, stated “On this journey of bringing more patients to clinical trials as part of their care, Devana’s IGNITE for sites platform is a key technology in advancing the IRO model and offerings of Javara as a reliable solution for both healthcare and biopharmaceutical partners.”

Added Barry Lake, CEO of Devana “We are delighted to align with Javara to provide innovative solutions that drive value for patients, healthcare systems and biopharmaceutical companies and CROs. At Devana Solutions, we wanted to create a suite of products that would connect key stakeholders within the clinical trials ecosystem through better data allowing for better decisions and better outcomes.  Javara’s strategy and offerings are unique and there’s no doubt they will drive better outcomes for their health system clients, while contributing to the advancement of the drug development process. ”

Javara is currently onboarding the IGNITE software for immediate use to enhance business decisions and performance outcomes.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. To learn more visit https://devanasolutions.com

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151